Aim: Adherence to dietary recommendations has been linked to a reduced risk of developing hepatocellular carcinoma (HCC) and dying of chronic liver disease. However, its role in the prognosis of HCC is still unclear. We prospectively investigated the association of two dietary quality indices, the Chinese Healthy Eating Index (CHEI) and the Healthy Eating Index-2015 (HEI-2015), with all-cause and HCC-specific mortality in a large prospective cohort of HCC survivors.
Methods: We included 887 patients with newly diagnosed, previously untreated HCC enrolled in the Guangdong Liver Cancer Cohort (GLCC) between September 2013 and April 2017 in the analysis. CHEI and HEI-2015 scores were calculated based on the dietary intake in the year before diagnosis of HCC. Cox proportional hazards regression models were used to estimate multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) for each index.
Results: During a median follow-up of 797 days, 389 deaths were identified, including 347 from HCC. Higher CHEI scores, reflecting favorable adherence to the 2016 Dietary Guidelines for Chinese, were associated with a lower risk of all-cause mortality (T vs. T : HR = 0.75, 95% CI: 0.58-0.98) and HCC-specific mortality (T vs. T : HR = 0.74, 95% CI: 0.56-0.98). Non-significant, inverse associations of HEI-2015 score with all-cause mortality (T vs. T : HR = 0.86, 95% CI: 0.67-1.11) and HCC-specific mortality (T vs. T : HR = 0.93, 95% CI: 0.71-1.21) were suggested.
Conclusions: Our findings suggest that better adherence to the 2016 Dietary Guidelines for Chinese may reduce the risk of all-cause and HCC-specific mortality in patients with HCC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/hepr.13548 | DOI Listing |
JAMA Netw Open
September 2024
Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco.
Importance: Hepatocellular carcinoma (HCC) is the leading oncologic cause of death among patients with cirrhosis, but large studies examining mortality trends are lacking.
Objective: To evaluate survival among patients with HCC in one of the largest integrated health care systems in the US.
Design, Setting, And Participants: This retrospective cohort study included 3441 adult patients who received a diagnosis of HCC between January 1, 2006, and December 31, 2019, with end of follow-up on December 31, 2020.
PLoS One
September 2024
Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States of America.
Introduction: We assessed chronic liver disease (CLD)-related mortality in the U.S. using death data (2011-2021) obtained from National Vital Statistics System (NVSS).
View Article and Find Full Text PDFJ Surg Res
October 2024
The Hiram C. Polk Jr, MD Department of Surgery, University of Louisville, Louisville, Kentucky. Electronic address:
Introduction: Hepatocellular carcinoma (HCC) occurs most often in a background of cirrhosis. Patients with noncirrhotic HCC represent a distinct population, which has been characterized in single-center studies, but has not been fully evaluated on a population level in the United States.
Materials And Methods: HCC cases from Surveillance, Epidemiology, and End-Results diagnosed between 2000 and 2020 were categorized as cirrhotic or noncirrhotic.
Am J Cancer Res
July 2024
Division of General Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University No. 111, Sec. 3, Xinglong Road, Wenshan District, Taipei 116, Taiwan.
This study aimed to evaluate the impact of different pre-transplant local treatments on the survival of liver transplantation (LTx) recipients with BCLC Stage A Hepatocellular Carcinoma (HCC). We analyzed data from the Taiwan Cancer Registry and National Health Insurance Research Databases spanning 2012 to 2018. Employing propensity score matching, patients were categorized into three groups: those receiving local treatments (180 patients), hepatectomy (179 patients), and combined treatments (180 patients).
View Article and Find Full Text PDFWe aimed to investigate the potential impact of metabolic risk factors and lifestyles on mortality in hepatocellular carcinoma (HCC) patients. From the Korean Central Cancer Registry database (2008-2016), 8,505 HCC patients were included in the analysis. Patients with 2 or more metabolic risk factors (n = 2384, 28.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!